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ABSTRACT
Background
Paracetamol (acetaminophen) poisoning is the leading cause of acute liver failure in Great
Britain and the United States. Successful interventions to reduced harm from paracetamol
poisoning are needed. To achieve this, the government of the United Kingdom introduced
legislation in 1998 limiting the pack size of paracetamol sold in shops. Several studies have
reported recent decreases in fatal poisonings involving paracetamol. We use interrupted time-
series analysis to evaluate whether the recent fall in the number of paracetamol deaths is
different to trends in fatal poisoning involving aspirin, paracetamol compounds, antidepres-
sants, or nondrug poisoning suicide.
Methods and Findings
We calculated directly age-standardised mortality rates for paracetamol poisoning in England
and Wales from 1993 to 2004. We used an ordinary least-squares regression model divided into
pre- and postintervention segments at 1999. The model included a term for autocorrelation
within the time series. We tested for changes in the level and slope between the pre- and
postintervention segments. To assess whether observed changes in the time series were
unique to paracetamol, we compared against poisoning deaths involving compound
paracetamol (not covered by the regulations), aspirin, antidepressants, and nonpoisoning
suicide deaths. We did this comparison by calculating a ratio of each comparison series with
paracetamol and applying a segmented regression model to the ratios. No change in the ratio
level or slope indicated no difference compared to the control series. There were about 2,200
deaths involving paracetamol. The age-standardised mortality rate rose from 8.1 per million in
1993 to 8.8 per million in 1997, subsequently falling to about 5.3 per million in 2004. After the
regulations were introduced, deaths dropped by 2.69 per million (p¼0.003). Trends in the age-
standardised mortality rate for paracetamol compounds, aspirin, and antidepressants were
broadly similar to paracetamol, increasing until 1997 and then declining. Nondrug poisoning
suicide also declined during the study period, but was highest in 1993. The segmented
regression models showed that the age-standardised mortality rate for compound paracetamol
dropped less after the regulations (p¼ 0.012) but declined more rapidly afterward (p¼ 0.031).
However, age-standardised rates for aspirin and antidepressants fell in a similar way to
paracetamol after the regulations. Nondrug poisoning suicide declined at a similar rate to
paracetamol after the regulations were introduced.
Conclusions
Introduction of regulations to limit availability of paracetamol coincided with a decrease in
paracetamol-poisoning mortality. However, fatal poisoning involving aspirin, antidepressants,
and to a lesser degree, paracetamol compounds, also showed similar trends. This raises the
question whether the decline in paracetamol deaths was due to the regulations or was part of a
wider trend in decreasing drug-poisoning mortality. We found little evidence to support the
hypothesis that the 1998 regulations limiting pack size resulted in a greater reduction in
poisoning deaths involving paracetamol than occurred for other drugs or nondrug poisoning
suicide.
The Editors’ Summary of this article follows the references.
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Paracetamol (acetaminophen) is an effective, cheap, and
widely available analgesic. However, poisoning due to para-
cetamol is a common problem worldwide [1] and is currently
the most common cause of acute liver failure in UK [2] and
the United States [3]. Each year in England and Wales, there
are approximately 150 deaths and over 30,000 hospital
admissions due to paracetamol overdose [4]. Successful
interventions to reduce harm from paracetamol poisoning
are needed.
In September 1998, the Medicines Control Agency of the
United Kingdom introduced legislation to limit the avail-
ability of paracetamol and thereby reduce mortality and
morbidity due to paracetamol poisoning [5,6]. Availability of
aspirin was similarly limited to avoid substitution. Pack sizes
were limited to 16 tablets at general sales outlets and 32
tablets at pharmacies. The maximum number of tablets that
can be sold in any single purchase without a prescription was
limited to 100 tablets. Concurrently, the government agreed
voluntary restrictions with the pharmaceutical industry and
retailers to sell no more than 32 tablets in any single
purchase.
Several studies have shown that paracetamol poisoning
deaths in England and Wales have decreased, although they
a r eu n a b l et oc o n v i n c i n g l ya t t r i b u t et h i st ot h e1 9 9 8
regulations [7–9]. Here we use interrupted time-series
analysis to assess whether the recent fall in the number of
paracetamol deaths is different to trends in fatal poisoning
involving aspirin, paracetamol compounds, antidepressants,
or nondrug poisoning suicide.
Methods
Mortality Data
The Ofﬁce for National Statistics (ONS) maintains a
dedicated database of drug-poisoning deaths in England
and Wales since 1993. Drug-poisoning deaths are extracted
from the national deaths database using speciﬁc International
Classiﬁcation of Diseases codes for the underlying cause of
death [10]. In addition to data supplied in the cause of death
section of the coroner’s death certiﬁcate, the database also
contains textual information supplied voluntarily and in
conﬁdence by coroners to ONS about circumstances of the
death, which may include more detailed information from an
inquest investigation about the drugs involved [10]. Two
trained ONS coders independently code the textual informa-
tion about all drugs mentioned by the coroner. Any
discrepancies are resolved and discussed with a senior
medical epidemiologist. The manual coding allows the data-
base to be queried and all deaths identiﬁed where speciﬁc
drugs were detected by the coroner. About 90% of drug-
poisoning deaths have speciﬁc information about the drug(s)
taken [4].
We identiﬁed deaths in which paracetamol was mentioned
on the death certiﬁcate, with or without alcohol or other
nonparacetamol drugs. Where death certiﬁcates mentioned
paracetamol along with codeine, dihydrocodeine, dextro-
propoxyphene, or as part of a paracetamol-containing drug
(e.g., Paramax and Propain), these were deﬁned as being
paracetamol compound-related deaths. To ascertain whether
changes in mortality trends for paracetamol poisoning were
coincidental rather than due to the intervention, we
compared paracetamol deaths with paracetamol compounds,
aspirin, antidepressant drugs, and suicide deaths involving
methods other than drug poisoning [11]. We chose anti-
depressants because along with paracetamol, they are the
most common substances mentioned in drug-related poison-
ing suicides [11]. Therefore, if changes in the time series for
paracetamol were due to overall changes in the propensity to
commit suicide by drug overdose rather than the regulations,
we would expect to see similar changes for antidepressants.
Furthermore, analysing nondrug poisoning suicides should
give an indication of any effect of suicide trends overall. We
did not compare deaths involving paracetamol with those
involving opiates, even though they make up about half of all
drug-poisoning deaths [4]. This was because the epidemiology
of opiate-related deaths differs markedly from other drug-
related deaths, having increased more than 6-fold between
1993 and 2000 [12].
Analysis
We calculated annual directly age-standardised mortality
rates using the European Standard population. For the
interrupted time-series analysis, we used segmented linear
regression, which divides a time series into pre- and
postintervention segments [13]. As the regulations were
introduced at the end of 1998, we chose 1999 as the
intersection between segments (i.e., the intervention). A
linear regression model has two parameters: the level and
slope. Therefore the difference between the two segments can
be quantiﬁed by testing the change in these two parameters
(Equation 1). A change in level between the pre- and
postintervention segments indicates a step-change, and a
change in slope indicates a change in trend.
Yt ¼ b0 þ b1 3timet þ b2 3interventiont
þb3 3time after interventiont þ et
ð1Þ
b0 estimates the baseline level of the outcome at the
beginning of the time series. b1 estimates the preintervention
trend where time is a continuous variable indicating the time
in years at time t from the start of the study period. b2
estimates the change in level postintervention where inter-
ventiont ¼ 0 before the intervention, and interventiont ¼ 1 after
the intervention. b3 estimates the change in postintervention
trend where time after intervention is a continuous variable
indicating the number of years after the start of the
intervention at time t and is coded as zero before the
intervention. et includes random error and autocorrelation.
Time-series data are often autocorrelated (events closer
together in a time series tend to be more similar than events
further apart in time) [14]. Hence, the model residuals are not
independent (a key assumption when using ordinary least-
squares regression) [15]. Nonindependence of the residuals
can lead to biased standard deviations, which can over- or
underestimate tests of statistical signiﬁcance [16]. We there-
fore corrected for autocorrelation effects by including a term
in the regression model for the lagged residuals (i.e., the
residual of the regression model moved to the previous time
points in the time series).
We considered whether changes in level and slope for
paracetamol poisoning were different from the comparison
series (compound paracetamol, aspirin, antidepressants, and
nondrug poisoning suicide). We made this comparison by
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Paracetamol Poisoningcalculating a ratio for each year by dividing the age-
standardised mortality rates for each comparison group by
paracetamol and used segmented regression to assess changes
in the level and slope of the ratios, again using 1999 as the
intersection between segments. The null hypothesis was that
changes in the age-standardised mortality rates for para-
cetamol and the comparison groups were similar. We rejected
the null hypothesis if there was statistical evidence that the
model parameters (level or slope) of the ratios were statisti-
cally different from 0 at the p , 0.05 level between the pre-
and postintervention segments. The 95% conﬁdence intervals
of the ratio of the model parameters summarize the degree of
difference between paracetamol and the control series that
can be excluded as not being statistically different. All
analysis was done using Stata 8.2 (Stata, http://www.stata.com).
Results
Between 1993 and 2004, 2,196 poisoning deaths occurred
involving paracetamol in England and Wales. Number of
deaths were similar among males and females, and hence we
present results for males and females combined. Changes in
age-speciﬁc mortality rates were similar across all age groups
during the study period (unpublished data). For paracetamol
poisoning the age-standardised mortality rate was 8.1 per
million in 1993, peaking at 8.8 per million in 1997, followed
by a decrease to 5.3 per million in 2004 (Figure 1; Table 1).
The results of the segmented regression analysis for
paracetamol poisoning are summarised in Table 2. There
was evidence of ﬁrst-order autocorrelation (p¼0.033), and so
we included a term for it in the ﬁnal model. There was a
downward step-change in the annual age-standardised mor-
tality rate, of  2.69 per million (p ¼ 0.003) between the pre-
and postintervention periods, while there was no evidence of
a change in slope (p ¼ 0.128) in the postintervention period.
About twice as many deaths involved paracetamol com-
pounds (n ¼ 4,378), less than one-fourth of deaths involving
aspirin (n ¼ 457), two and a half times as many involving
antidepressants (n ¼ 5,602), and almost 20 times as many
deaths due to nondrug poisoning suicide (n ¼ 43,824) (Table
3). The median age at death for aspirin, 62 years, was higher
than other groups (Table 3). A similar proportion of deaths
involved males and females for all three drug-poisoning
groups, but not nondrug suicide deaths, for which about 80%
were male. Compared to paracetamol compounds and
antidepressants, paracetamol deaths were less likely to
mention other drugs, whereas aspirin deaths were more
likely to mention other drugs. The majority of deaths were
suicides for all groups except aspirin, among which only
about half were considered suicide.
Age-standardised mortality rates for paracetamol com-
pounds, aspirin, antidepressants, and nonpoisoning suicides
all declined over the study period (Figure 1; Table 1). In the
preintervention period, rates for paracetamol compounds
and antidepressants increased slightly, whereas paracetamol-
poisoning deaths and nondrug poisoning suicides were
relatively stable (Figure 1). In the postintervention period,
rates for all series declined, with paracetamol compounds
declining the most.
A summary of the segmented regression models applied to
the ratios of the comparison with paracetamol series is shown
in Table 4. The time series for paracetamol compounds
Figure 1. Directly Age-Standardised Mortality Rates per Million, England
and Wales, 1993–2004
doi:10.1371/journal.pmed.0040105.g001
Table 1. Number of Deaths and Age-Standardised Mortality Rate per Million for Poisoning Involving Paracetamol, Paracetamol
Compounds, Antidepressants, and Nondrug Poisoning Suicide, England and Wales
Year Paracetamol Compound Paracetamol Aspirin Antidepressants Nonpoisoning Suicides
Deaths Rate Deaths Rate Deaths Rate Deaths Rate Deaths Rate
1993 222 8.1 311 11.8 65 2.3 461 17.9 3,930 150.6
1994 194 7.1 349 13.1 53 1.9 478 18.7 3,818 145.5
1995 220 8.0 396 14.8 50 1.7 489 18.9 3,771 144.0
1996 188 7.0 378 14.0 56 2.0 540 20.9 3,554 135.1
1997 235 8.8 434 16.3 50 1.8 539 20.9 3,526 134.3
1998 214 7.9 396 14.5 41 1.4 510 19.5 3,799 144.5
1999 155 5.5 404 14.7 28 0.9 493 18.8 3,836 145.0
2000 155 5.5 396 14.4 24 0.8 449 17.0 3,643 136.8
2001 175 6.2 370 13.3 27 0.9 416 15.7 3,457 128.5
2002 126 4.5 337 11.7 22 0.6 392 14.8 3,536 131.4
2003 159 5.7 307 10.7 22 0.7 424 15.8 3,500 128.4
2004 153 5.3 300 10.5 19 0.6 411 15.1 3,454 125.9
doi:10.1371/journal.pmed.0040105.t001
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Paracetamol Poisoningdiffered from paracetamol, having a greater step-change
(coefﬁcient ¼ 0.81; p ¼ 0.012) and greater postintervention
decline (coefﬁcient ¼  0.19; p ¼ 0.031). In contrast, no
statistical evidence suggested that the change in trends for
aspirin or antidepressants was different to the change in
paracetamol trends. The ratio of aspirin versus paracetamol
showed a similar postintervention step-change (coefﬁcient ¼
0.01; p , 0.779) and slope (coefﬁcient ¼  0.003; p ¼ 0.834).
Likewise, antidepressants had a similar step-change (p ¼
0.108) and change in slope (p ¼ 0.250). Nondrug poisoning
suicide, on the other hand, showed a statistically marked
upward step-change (coefﬁcient ¼ 8.44; p ¼ 0.025) but a
similar postintervention trend (p ¼ 0.865). The upward step-
change in the ratio of paracetamol versus nondrug poisoning
suicide was due to a fall in paracetamol deaths. Examination
of the number of deaths in Table 1 and the age-standardised
rates in Figure 1 shows that only a small increase occurred in
nondrug poisoning suicide between 1998 and 2000, which was
within the bounds of measurement error and random annual
variation.
Discussion
Between 1993 and 2004, there was a decline in age-
standardised mortality rates from paracetamol poisoning.
The decline did not occur gradually over the study period, but
there was a downward step-change coinciding with the
introduction of regulations to limit availability of para-
cetamol. This step-change was similar for poisoning deaths
involving antidepressants and aspirin, but not paracetamol
compounds or nondrug poisoning suicide. The 95% con-
ﬁdence intervals of the coefﬁcients for aspirin and anti-
depressants show that statistical power was sufﬁcient to detect
a relatively small divergence in the ratios with paracetamol,
thereby increasing our conﬁdence in the conclusion that
trends were similar to paracetamol poisoning.
Strengths and Limitations
Ideally, the impact of health care interventions should be
assessed using an experimental study design, such as a
randomised controlled trial [17]. However, where interven-
tions are implemented across an entire population, research-
ers do not have control over intervention allocation, so
nonexperimental study designs must be used instead [17,18].
Interrupted time-series methods have several advantages over
other quasi-experimental studies, because they are less likely
to be inﬂuenced by a number of biases [18]. For example,
underlying increasing or decreasing secular trends may
contribute to observed intervention effects. This variation
may also occur where cyclical effects introduce localised
upward or downward trends in the time series. Interventions
that may be short-lived may erroneously report maximal
effects if short time series are analysed. Finally, autocorre-
lated data means that adjacent data points can be more
similar (positive autocorrelation) or dissimilar (negative
autocorrelation), leading to under- or overestimates of effect,
respectively.
However, as with all nonexperimental designs, causal
inference from interrupted time-series designs is limited
because it is impossible to rule out alternative explanations
for observed changes in time series [18]. One such explan-
ation is a change in the way data are recorded (data artefact),
and in our study, coding of deaths changed from Interna-
tional Classiﬁcation of Diseases-9 to International Classiﬁca-
tion of Diseases-10 in 2001. However, we think this is an
unlikely explanation for our ﬁndings: a bridge coding study
showed no impact on the number of drug-poisoning deaths
[19], and the ONS database does not use International
Classiﬁcation of Diseases codes to identify which drugs were
involved [10]. Furthermore, as the coroner’s primary function
is to investigate the possibility of criminal involvement,
information from death certiﬁcates may not be ideal for
surveillance of drug-related deaths [10]. Information on the
death certiﬁcate may be incomplete, as toxicological exami-
nation may not be conducted or may only test for a limited
range of drugs; about 10% of drug-poisoning deaths have no
speciﬁc information on the drug(s) taken [4]. Where multiple
substances are mentioned on the death certiﬁcate, it is not
possible to establish which drug was the most likely to have
Table 2. Interrupted Time-Series Regression Analysis of Age-
Standardised Mortality Rates for Paracetamol Poisoning,
Adjusted for First-Order Autocorrelation
Parameter Coefficient Standard Error t Statistic p-Value
Baseline trend b1 0.27 0.15 1.83 0.117
Step-change after
1998 regulations b2
 2.69 0.57  4.68 0.003
Trend change after
1998 regulations b3
 0.33 0.19  1.76 0.128
First-order
autocorrelation
 0.69 0.25  2.76 0.033
Intercept b0 6.68 0.63 10.54 ,0.0001
b symbols refer to those in Equation 1.
doi:10.1371/journal.pmed.0040105.t002
Table 3. Number of Deaths, Median Age, and Percentages: Male, Mentions of Other Drugs, and Suicides, England and Wales 1993–2004
Characteristics Paracetamol Only Compound Paracetamol Aspirin Antidepressants Nondrug Poisoning Suicide
Number of deaths 2,196 4,378 457 5,602 43,824
Median age (interquartile range) 48 (35–64) 44 (33–61) 62 (47–74) 41 (32–52) 41 (31–56)
Male (%) 47 53 52 51 82
Mention of other drugs (%) 19 20 42 34 –
Suicide (%) 75 81 22 78 –
doi:10.1371/journal.pmed.0040105.t003
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Paracetamol Poisoningcaused the death. This may lead to misclassiﬁcation of some
deaths as due to paracetamol. However, there is no evidence
to suggest that the recording practice of coroners has
changed over time, and no guidelines or recommendations
about the investigation of poisoning deaths have been
published that may have changed their recording with the
ONS system.
An alternative explanation is that an abrupt change in the
population at risk coincided with the introduction of the
intervention. This change could occur if, for example, the
1998 regulations inadvertently encouraged retailers to be
more cautious about selling paracetamol to young girls, the
group most frequently admitted to hospital for paracetamol
poisoning [8]. Again, we think this is unlikely because age-
speciﬁc mortality rates were similar across all age groups
during the time series.
A third explanation is that external inﬂuences may have
caused longer-term cyclical trends that we have not taken
into account, such as changing unemployment or other
macrolevel effects [20]. Such inﬂuences could explain the
similarity of the three drug-poisoning time series in our
study.
A major limitation of previous studies assessing the impact
of the 1998 regulations on paracetamol-poisoning mortality
is that no comparison group was used. However, identifying a
suitable comparator is not straightforward, and hence we
chose multiple comparison groups. Aspirin share many of the
characteristics of paracetamol: it is a readily available
analgesic and is freely available over the counter without
prescription. However, aspirin is not an ideal comparator as
it is less toxic than paracetamol, many more deaths involving
aspirin also involve other drugs, the median age at death is
greater, and fewer aspirin-related deaths are considered
suicides. Furthermore, aspirin was also subject to pack-size
restrictions, which may explain why trends in aspirin-related
deaths are similar to paracetamol. Antidepressant-related
deaths are far more similar to paracetamol in terms of
median age at death and involvement in suicide, however,
they too are frequently taken with other drugs and unlike
paracetamol, are only available in prescription. Given these
differences, it is even more striking that mortality trends
involving these two drugs are similar. Paracetamol com-
pounds include a number of different paracetamol-contain-
ing drugs. Like antidepressants, many are only available on
prescription, and some are far more toxic in overdose than
paracetamol. One such compound, co-proxamol, was recently
banned in the United Kingdom because of its high toxicity
and frequent involvement in poisoning deaths [21].
Conclusions
We have shown that paracetamol-poisoning deaths de-
creased around the same time that the regulations were
introduced. This observation is consistent with other studies
[8,9,22]. However, we have also shown that poisoning deaths
involving aspirin, antidepressants, and to a lesser degree,
paracetamol compounds followed similar trends. This ﬁnding
raises the question whether the concurrent introduction of
the 1998 regulations and reduction in paracetamol-poisoning
deaths following was coincidental rather than causal. We
found little evidence to support the hypothesis that the 1998
regulations limiting pack size resulted in a greater reduction
in poisoning deaths than occurred for other drugs or
nondrug poisoning suicides.
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Editors’ Summary
Background. Paracetamol—known as acetaminophen in the United
States—is a cheap and effective painkiller. It is widely used to relieve
minor aches and pains as well as fevers and headaches. Recommended
doses of paracetamol are considered safe in humans, but overdoses are
toxic and can cause liver failure and death. Because this drug is very easy
to get hold of, there are many overdoses each year, either accidental or
deliberate. In the UK, paracetamol poisoning is the most common cause
of acute liver failure. Toward the end of 1998, new laws were introduced
in the UK to try to reduce the number of paracetamol overdoses. These
laws said that pharmacies could not sell packs of paracetamol containing
more than 32 tablets and other shops could not sell packs with more
than 16 tablets. One of the reasons behind the introduction of this law
was that many suicides are not preplanned and, therefore, if it was
harder for people to get hold of or keep large quantities of tablets, they
might be less likely to attempt suicide or accidentally overdose.
Why Was This Study Done? Following the introduction of these new
laws, the number of deaths caused by paracetamol overdose in the UK
dropped. However, it is possible that the drop in deaths came about for
a variety of different reasons and not just as a result of the new laws on
paracetamol pack size. For example, the suicide rate might have been
falling anyway due to other changes in society and the fall in death rate
from paracetamol might just have been part of that trend. It is important
to find out whether the legal changes that were introduced to address a
public health problem did in fact bring about a change for the better.
This knowledge would also be relevant to other countries that are
considering similar changes.
What Did the Researchers Do and Find? The researchers used data
from the Office of National Statistics, which holds information on drug
poisoning deaths in England and Wales. These data were then broken
down by the type of drug that was mentioned on the death certificate.
The researchers compared death rates involving the following drugs:
paracetamol; paracetamol-containing compounds (which were not
subject to the new pack size laws); aspirin; antidepressant drugs; and
then finally non-drug poisoning suicides. The reason for comparing
death rates involving paracetamol against death rates involving other
drugs, or non-drug suicide, was that this method would allow the
researchers to see if the drop in paracetamol deaths followed overall
trends in the poisoning or suicide rates or not. If the paracetamol death
rate dropped following introduction of the new laws but the rates of
other types of poisoning or suicide did not, then there would be a link
between the new laws and a fall in paracetamol suicides. The researchers
compared these death data within specific time periods before the end
of 1998 (when the new laws on paracetamol pack size were introduced)
and after.
Overall, there were nearly 2,200 deaths involving paracetamol between
1993 and 2004. The number of deaths per year involving paracetamol
dropped substantially when comparing the periods of time before the
end of 1998 and after it. However, the number of deaths per year
involving any drug, and the non-drug suicides, also fell during this period
of time. When comparing the trends for paracetamol deaths with other
poisoning or suicide deaths, the researchers did not find any statistical
evidence that the fall in paracetamol deaths was any different to the
overall trend in poisoning or suicide death rates.
What Do These Findings Mean? Although the paracetamol death rate
fell immediately following the new laws on pack size, this study suggests
the link might just be coincidence. The researchers could not find any
data supporting the idea that the new laws caused a drop in
paracetamol deaths. However, this was an observational study, not a
true experimental one: the researchers here were clearly not able to set
up equivalent ‘‘experimental’’ and ‘‘control’’ groups for comparison. It is
very difficult to prove or disprove conclusively that new laws such as this
are, or are not, effective.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040105
  Information is available from Medline Plus about suicide
  Wikipedia has an entry on paracetamol (note that Wikipedia is an
internet encyclopedia anyone can edit)
  Information about regulation of drugs in the UK is available from the
Medicines and Healthcare Regulatory Agency
  The Office for National Statistics provides key economic and social
data about the UK, and is involved in many other important projects
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